Literature DB >> 12370335

Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL.

Kiley R Prilliman1, Edward E Lemmens, Georgia Palioungas, Thomas G Wolfe, James P Allison, Arlene H Sharpe, Stephen P Schoenberger.   

Abstract

Although APC activation via CD40-CD40L signaling plays a critical role in enabling CD4(+) T cells to provide the "help" necessary for cross-priming of naive CTL, it is unclear how this makes the APC competent for priming. We have investigated the roles of B7-1/B7-2 and their receptors [corrected] CD28/CTLA-4 in cross-priming of CD4-dependent CTL in vivo. We find that both CD28 and B7-1/B7-2 are required for CD40-activated APC to cross-prime CTL, and that priming by CD40-activated APC was prevented by blockade of CD28. Conversely, augmenting CD28 signals with an agonistic Ab bypassed the requirement for CD4(+) T help or CD40 activation. Interestingly, blockade of the negative regulatory B7 receptor CTLA-4 failed to prime CTL in the absence of T help. These results support a model in which activation-induced up-regulation of B7 molecules on APC leads to increased CD28 signaling and a commitment to cross-priming of CD4-dependent CTL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370335     DOI: 10.4049/jimmunol.169.8.4094

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

Review 3.  Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-03-17       Impact factor: 7.486

Review 4.  TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

5.  Immunity, cancer and aging: lessons from mouse models.

Authors:  Cheryl E Myers; Noweeda N Mirza; Joseph Lustgarten
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

6.  Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression.

Authors:  Monika C Wolkers; Carmen Gerlach; Ramon Arens; Edith M Janssen; Patrick Fitzgerald; Ton N Schumacher; Jan Paul Medema; Douglas R Green; Stephen P Schoenberger
Journal:  Blood       Date:  2011-11-29       Impact factor: 22.113

7.  CD28 is required for optimal induction, but not maintenance, of vaccine-induced immunity to Blastomyces dermatitidis.

Authors:  Marcel Wüthrich; Tom Warner; Bruce S Klein
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

8.  Expression of diabetes-associated genes by dendritic cells and CD4 T cells drives the loss of tolerance in nonobese diabetic mice.

Authors:  Emma E Hamilton-Williams; Xavier Martinez; Jan Clark; Sarah Howlett; Kara M Hunter; Daniel B Rainbow; Li Wen; Mark J Shlomchik; Jonathan D Katz; Georg F Beilhack; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

9.  Selective addition of CXCR3(+) CCR4(-) CD4(+) Th1 cells enhances generation of cytotoxic T cells by dendritic cells in vitro.

Authors:  Sung Hee Yoon; Sun Ok Yun; Jung Yong Park; Hee Yeun Won; Eun Kyung Kim; Hyun Jung Sohn; Hyun Il Cho; Tai Gyu Kim
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

Review 10.  Memory T cells need CD28 costimulation to remember.

Authors:  Alina C Boesteanu; Peter D Katsikis
Journal:  Semin Immunol       Date:  2009-03-05       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.